---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-013183"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2026-04-23T23:59:59+00:00"
generated_at: "2026-05-15T04:35:27.191586+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision closes $3.47M Series C-2 preferred; issues $11M Series D for Flyte acquisition

## Summary
- 3,470 shares of Series C-2 Preferred at $1,000 stated value sold for gross proceeds of $3,470,000.
- 11,028 shares of Series D Preferred ($11.03M stated value) issued to SEG Jets and Creatd for Fly Flyte acquisition.
- Series C-2 conversion price $0.883/share, floor $0.35; Series D conversion price $1.1038/share, subject to reduction.
- Stockholder approval obtained April 15, 2026; proceeds for working capital and general corporate purposes.
- Beneficial ownership limitation initially 4.99%, can be increased to 9.99% on 61 days' notice.

## SEC filing metadata
- accession: 0001437749-26-013183
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2026-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774926013183/0001437749-26-013183-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774926013183/vtak20260420_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-013183
- JSON: https://secwatch.observer/filing/0001437749-26-013183.json
- Plain text: https://secwatch.observer/filing/0001437749-26-013183.txt

## Key facts
- Equity Issuances
  Catheter Precision, Inc. issued 3,470 shares of preferred stock to the purchasers signatory thereto for aggregate gross proceeds of $3,470,000.
  - Security: preferred stock
  - Shares: 3,470 shares
  - Purchaser: the purchasers signatory thereto
  - Consideration: aggregate gross proceeds of $3,470,000
  source text: Issuance of Series C-2 Convertible Preferred Stock On April 21, 2026, Catheter Precision, Inc. (the "Company") consummated the closing (the "Series C-2 Closing") of its previously disclosed sale and issuance of an aggregate of 3,470 shares of the Company's newly designated Series C-2 Convertible Preferred Stock, par value $0.0001 per share and stated value of $1,000 per share (the "Series C-2 Preferred Stock"), for aggregate gross proceeds of $3,470,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774926013183/0001437749-26-013183-index.htm
- Governance Changes
  Catheter Precision, Inc.: Filed Series C-2 Certificate of Designation designating 3,470 shares as Series C-2 Convertible Preferred Stock and Series D Certificate of Designation designating 11,028 shares as Series D Convertible Preferred Stock (effective 2026-04-17).
  - Change: charter amendment
  - Effective: 2026-04-17
  source text: On April 17, 2026, the Company filed each of the Series C-2 Certificate of Designation and the Series D Certificate of Designation with the Secretary of State of the State of Delaware.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774926013183/0001437749-26-013183-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.